Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6G91

Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeROTATING ANODE
Source detailsRIGAKU FR-E SUPERBRIGHT
Temperature [K]100
Detector technologyPIXEL
Collection date2015-02-04
DetectorDECTRIS PILATUS 300K
Wavelength(s)1.54178
Spacegroup nameP 1 21 1
Unit cell lengths48.775, 70.721, 60.355
Unit cell angles90.00, 109.34, 90.00
Refinement procedure
Resolution44.360 - 1.800
R-factor0.169
Rwork0.166
R-free0.22000
Structure solution methodFOURIER SYNTHESIS
RMSD bond length0.013
RMSD bond angle1.090
Data reduction softwareXDS
Data scaling softwareAimless
Phasing softwareBUSTER
Refinement softwareBUSTER (2.11.7)
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]46.0201.820
High resolution limit [Å]1.7961.800
Rmerge0.410
Rmeas0.0570.410
Number of reflections34922919
<I/σ(I)>11.3
Completeness [%]96.783.1
Redundancy2.6
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, SITTING DROP7.22930.1M HEPES/NaOHpH=7.2, 34.0%w/v MPEG 2000, 0.02M Mercaptoethanol, 0.2M (NH4)2SO4

219869

PDB entries from 2024-05-15

PDB statisticsPDBj update infoContact PDBjnumon